Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 222
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
PTSF84 – A Brief Check-in From Wonderland
PT272 – Veterans Day 2021
How Likely Are Bad Trips and Flashbacks from LSD?
COMPASS Pathways announces positive topline results from groundbreaking phase IIb trial...
PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers
Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to...
Psychedelic Bulletin: COMPASS Targets PTSD; Detroit Decriminalizes Psychedelics; We Speak to...
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye...
MindMed Appoints Dr. Maria Oquendo to its Scientific Advisory Board
PT270 – Dr. Rachel Yehuda – Research Trials and The Future...
Load more